Found: 39
Select item for more details and to access through your institution.
Cellular Resistance to Camptothecins.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 60, doi. 10.1111/j.1749-6632.1996.tb26377.x
- By:
- Publication type:
- Article
Clinical Studies of Topotecan.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 264, doi. 10.1111/j.1749-6632.1996.tb26396.x
- By:
- Publication type:
- Article
Induction of Apoptosis in Malignant and Camptothecin-resistant Human Cells<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 143, doi. 10.1111/j.1749-6632.1996.tb26383.x
- By:
- Publication type:
- Article
Synthesis of CPT-11 (Irinotecan Hydrochloride Trihydrate).
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 13, doi. 10.1111/j.1749-6632.1996.tb26372.x
- By:
- Publication type:
- Article
The Cell Cycle Effects of Camptothecin<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 93, doi. 10.1111/j.1749-6632.1996.tb26379.x
- By:
- Publication type:
- Article
Schedule-dependent Efficacy of Camptothecins in Models of Human Cancer<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 188, doi. 10.1111/j.1749-6632.1996.tb26388.x
- By:
- Publication type:
- Article
The Effect of Camptothecin on Topoisomerase I Catalysis<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 50, doi. 10.1111/j.1749-6632.1996.tb26376.x
- By:
- Publication type:
- Article
Using Yeast to Understand Drugs that Target Topoisomerases<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 32, doi. 10.1111/j.1749-6632.1996.tb26374.x
- By:
- Publication type:
- Article
Chemistry of the Camptothecins in the Bloodstream.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 29, doi. 10.1111/j.1749-6632.1996.tb26373.x
- By:
- Publication type:
- Article
Radiation Enhancement by 9-Aminocamptothecin.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 312, doi. 10.1111/j.1749-6632.1996.tb26403.x
- By:
- Publication type:
- Article
9-Aminocamptothecin and Beyond.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 231, doi. 10.1111/j.1749-6632.1996.tb26393.x
- By:
- Publication type:
- Article
Topoisomerase I Inhibition by the Camptothecin Analog G1147211C.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 202, doi. 10.1111/j.1749-6632.1996.tb26389.x
- By:
- Publication type:
- Article
CPT-11.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 282, doi. 10.1111/j.1749-6632.1996.tb26398.x
- By:
- Publication type:
- Article
Camptothecin and Its Analogs.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 213, doi. 10.1111/j.1749-6632.1996.tb26391.x
- By:
- Publication type:
- Article
Concluding Remarks.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 327, doi. 10.1111/j.1749-6632.1996.tb26408.x
- By:
- Publication type:
- Article
Phase I Clinical and Pharmacological Studies of 20-(S)-Camptothecin and 20-(S)-9-Nitrocamptothecin as Anticancer Agents.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 224, doi. 10.1111/j.1749-6632.1996.tb26392.x
- By:
- Publication type:
- Article
Pharmacokinetic and Pharmacodynamic Studies of 9-Aminocamptothecin in Vitro against Human Cancer Cells.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 315, doi. 10.1111/j.1749-6632.1996.tb26404.x
- By:
- Publication type:
- Article
Clinical Trials of Irinotecan Hydrochloride (CPT, Campto Injection, Topotecin Injection) in Japan<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 292, doi. 10.1111/j.1749-6632.1996.tb26399.x
- By:
- Publication type:
- Article
Failure in DNA Elongation Predicts Sensitivity to Camptothecin in the Colon Cell Lines of the NCI Anticancer Drug Screen.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 308, doi. 10.1111/j.1749-6632.1996.tb26401.x
- By:
- Publication type:
- Article
Topoisomerase-I Inhibitors in the Management of Colon Cancer.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 256, doi. 10.1111/j.1749-6632.1996.tb26395.x
- By:
- Publication type:
- Article
Clinical Pharmacology and Pharmacodynamics of Irinotecan.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 164, doi. 10.1111/j.1749-6632.1996.tb26385.x
- By:
- Publication type:
- Article
Lowered Phosphorylation of Topoisomerase I Is a Direct Reason for Reduced Sensitivity of L5178Y-S Cells to Camptothecin.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 321, doi. 10.1111/j.1749-6632.1996.tb26406.x
- By:
- Publication type:
- Article
Factors Affecting Topotecan Sensitivity in Human Leukemia Samples<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 128, doi. 10.1111/j.1749-6632.1996.tb26382.x
- By:
- Publication type:
- Article
Camptothecin Resistance Related to Drug-induced Down-Regulation of Topoisomerase I and to Steps Occurring after the Formation of Protein-linked DNA Breaks<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 74, doi. 10.1111/j.1749-6632.1996.tb26378.x
- By:
- Publication type:
- Article
Introduction and Overview.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. ix, doi. 10.1111/j.1749-6632.1996.tb26370.x
- By:
- Publication type:
- Article
Second Generation Synthesis of (20S)-Camptothecin and Derivatives via a Cascade Radical Reaction.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 310, doi. 10.1111/j.1749-6632.1996.tb26402.x
- By:
- Publication type:
- Article
Pharmacokinetics of Camptothecins Administered Orally<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 157, doi. 10.1111/j.1749-6632.1996.tb26384.x
- By:
- Publication type:
- Article
Implications for the Use of Topoisomerase I Inhibitors in Treatment of Patients with Systemic Sclerosis<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 318, doi. 10.1111/j.1749-6632.1996.tb26405.x
- By:
- Publication type:
- Article
Induction of Apoptosis by Camptothecin and Topotecan.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 101, doi. 10.1111/j.1749-6632.1996.tb26380.x
- By:
- Publication type:
- Article
Protocols for the Treatment of Human Tumor Xenografts with Camptothecins.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 181, doi. 10.1111/j.1749-6632.1996.tb26387.x
- By:
- Publication type:
- Article
Identification of Topoisomerase I Mutations Affecting Both DNA Cleavage and Interaction with Camptothecin<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 111, doi. 10.1111/j.1749-6632.1996.tb26381.x
- By:
- Publication type:
- Article
Discovery to Clinic<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 1, doi. 10.1111/j.1749-6632.1996.tb26371.x
- By:
- Publication type:
- Article
Treatment of Central Nervous System Xenografts with Camptothecins.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 210, doi. 10.1111/j.1749-6632.1996.tb26390.x
- By:
- Publication type:
- Article
Clinical Pharmacology of 9-Aminocamptothecin.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 324, doi. 10.1111/j.1749-6632.1996.tb26407.x
- By:
- Publication type:
- Article
Cytotoxic Efficacy with Combinations of Topoisomerase I and Topoisomerase II Inhibitors in Sensitive and Multidrugresistant L1210 Mouse Leukemia Cells<sup>a</sup>.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 306, doi. 10.1111/j.1749-6632.1996.tb26400.x
- By:
- Publication type:
- Article
The Current Status of Irinotecan (CPT-11) in the United States.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 272, doi. 10.1111/j.1749-6632.1996.tb26397.x
- By:
- Publication type:
- Article
Mechanism of Action of Camptothecin.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 44, doi. 10.1111/j.1749-6632.1996.tb26375.x
- By:
- Publication type:
- Article
Trials of 9-Amino-20(S)-Camptothecin in Boston.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 247, doi. 10.1111/j.1749-6632.1996.tb26394.x
- By:
- Publication type:
- Article
Preclinical Antitumor Activity and Pharmacokinetics of Irinotecan (CPT-11) in Tumor-bearing Mice.
- Published in:
- Annals of the New York Academy of Sciences, 1996, v. 803, n. 1, p. 173, doi. 10.1111/j.1749-6632.1996.tb26386.x
- By:
- Publication type:
- Article